SCHEMBL22101540

SCHEMBL22101540

COc1cc(=O)n2cc(C)cc(F)c2n1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2C9 P11712 1/20 0.35
PIK3CB P42338 7/20 0.33
SMN1; SMN2 Q16637 3/20 0.33
HIF1A Q16665 1/20 0.33
ALDH1A1 P00352 3/20 0.32
HPGD P15428 1/20 0.32
PIK3CD O00329 5/20 0.32
PIK3CA P42336 5/20 0.32
KDM4E B2RXH2 2/20 0.31
RAB9A P51151 1/20 0.31
RXFP1 Q9HBX9 1/20 0.31
GSK3A P49840 2/20 0.31
GSK3B P49841 2/20 0.31
LMNA P02545 1/20 0.31
GRIN1 Q05586 1/20 0.30
GRIN2A Q12879 1/20 0.30
PDE2A O00408 1/20 0.30
PDE6D O43924 1/20 0.30
PDE6A P16499 1/20 0.30
PDE6G P18545 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22101541 0.84 MAPT (0.35) PIK3CBSMN1; SMN2ALDH1A1KDM4ERAB9A
SCHEMBL22101539 0.84 FFAR4 (0.35) CYP2C9PIK3CBSMN1; SMN2ALDH1A1HPGD
SCHEMBL22101910 0.84 ALDH1A1 (0.34) CYP2C9SMN1; SMN2ALDH1A1HPGDPIK3CA
SCHEMBL22393586 0.81 CYP2C9 (0.33) CYP2C9ALDH1A1HPGD
SCHEMBL22101536 0.81 THRB (0.38) PIK3CBSMN1; SMN2ALDH1A1PIK3CAKDM4E
SCHEMBL22101725 0.76 GRIN1 (0.40) SMN1; SMN2ALDH1A1HPGDKDM4ERAB9A
SCHEMBL22101522 0.76 PIK3CB (0.37) PIK3CBPIK3CDPIK3CA
SCHEMBL22101490 0.73 MAPT (0.35) PIK3CBALDH1A1HPGDKDM4ERAB9A
SCHEMBL22101184 0.73 CRHR1 (0.31) SMN1; SMN2ALDH1A1LMNAGRIN1GRIN2A
SCHEMBL32688229 0.72 ALDH1A1 (0.50) SMN1; SMN2ALDH1A1HPGDKDM4ERAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3666772-A1 DIARYLTHIOHYDANTOIN COMPOUND AS ANDROGEN RECEPTOR ANTAGONIST Chia Tai Tianqing Pharmaceutical Group Co., Ltd. (CN) 2020-06-17 EP disclosed